Concert Wealth Management’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-2,735
Closed -$229K 62
2017
Q2
$229K Sell
2,735
-295
-10% -$23.8K 0.22% 130
2017
Q1
$230K Sell
3,030
-58
-2% -$4.56K 0.05% 418
2016
Q4
$234K Sell
3,088
-2,368
-43% -$171K 0.05% 420
2016
Q3
$368K Buy
5,456
+41
+0.8% +$2.75K 0.04% 441
2016
Q2
$364K Buy
5,415
+243
+5% +$17.9K 0.05% 414
2016
Q1
$375K Sell
5,172
-178
-3% -$11.7K 0.05% 411
2015
Q4
$359K Buy
5,350
+478
+10% +$33.4K 0.05% 430
2015
Q3
$315K Sell
4,872
-58
-1% -$4.28K 0.04% 464
2015
Q2
$402K Buy
+4,930
New +$380K 0.05% 409
2015
Q1
Sell
-3,357
Closed -$254K 522
2014
Q4
$254K Sell
3,357
-1,817
-35% -$144K 0.04% 511
2014
Q3
$416K Buy
5,174
+930
+22% +$77.6K 0.06% 310
2014
Q2
$349K Sell
4,244
-59
-1% -$5.13K 0.04% 379
2014
Q1
$372K Sell
4,303
-30
-0.7% -$2.46K 0.05% 348
2013
Q4
$348K Buy
4,333
+791
+22% +$61.4K 0.04% 341
2013
Q3
$276K Buy
3,542
+45
+1% +$3.47K 0.04% 384
2013
Q2
$248K Buy
+3,497
New +$244K 0.04% 391

Other funds holding EMN

Concert Wealth Management's EMN Position: Q3 2017 in Review

Concert Wealth Management sold out of Eastman Chemical (EMN) in Q3 2017, closing a stake of 2,735 shares — an estimated $229K sold.

Concert Wealth Management first reported a position in EMN in Q2 2013 and held it in 16 quarters. The position peaked at $416K in Q3 2014. 622 funds tracked by Wall St. Rank hold EMN as of Q3 2017.

  • Concert Wealth Management reported no remaining Eastman Chemical position as of Q3 2017 after selling out during the quarter.
  • Concert Wealth Management sold 2,735 Eastman Chemical shares in Q3 2017, an estimated $229K.
  • Concert Wealth Management first reported a position in Eastman Chemical in Q2 2013 and held it in 16 quarters.
  • Concert Wealth Management's Eastman Chemical position peaked at $416K in Q3 2014.
  • 622 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2017.

Based on Concert Wealth Management's 13F filing for Q3 2017, filed 14 Nov 2017.